{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-020636","form_type":"8-K","ticker":"MRAI","cik":"0001844392","company_name":"Marpai, Inc.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.156523+00:00","generated_at":"2026-06-15T07:03:56.232757+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Marpai reports Q1 2023 net revenue $9.7M, operating loss $8.5M","bullets":["Net revenue $9.7M for Q1 2023, up 26.8% sequentially from $7.6M in Q4 2022, driven by full quarter of Maestro Health.","Operating loss $8.5M; net loss $8.9M; adjusted negative EBITDA $6.7M.","Covered employees under administered health plans were 41,571 as of Mar 31, 2023, down from 42,107 at Dec 31, 2022.","Q1 2023 expenses included $1.5M for Value Based Care Platform and $0.8M for unused facilities and severance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-020636","json":"https://secwatch.observer/filing/0000950170-23-020636.json","markdown":"https://secwatch.observer/filing/0000950170-23-020636.md","text":"https://secwatch.observer/filing/0000950170-23-020636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023020636/0000950170-23-020636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023020636/mrai-20230510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T07:03:56.232757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74590890adf92b60b2d9347e36db20428454c574","claim":"Marpai, Inc. reported first quarter ended March 31, 2023 results: revenue approximately $9.7 million, net income approximately $8.9 million.","evidence_excerpt":"all periods presented, and the results of Maestro Health, LLC (“Maestro Health”) since its acquisition on November 1, 2022. Financial Highlights • Net revenue of approximately $9.7 million for the three months ended March 31, 2023, compared to net revenue of approximately $7.6 million for the three months ended December 31, 2022, representing a sequential increase","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023020636/0000950170-23-020636-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"approximately $9.7 million"},{"label":"Net income","value":"approximately $8.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}